Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
To evaluate the safety and efficacy of 0.5% GL101 topical gel administered twice daily for 28 days in ameliorating adverse ocular side effects in patients under ongoing treatment with glaucoma medications.
Epistemonikos ID: 9e162aeb1b033e53d7f57657cd8bfdbae5ffbe92
First added on: May 12, 2024